SWEDEN | New TLV Rules Put Prevalence and Incidence Evidence at the Centre of Reimbursement Submissions
Please login to view this page.
EU | Council Position on Pharma Package Broadens Post-Authorisation Study Powers and RWD Recognition
Please login to view this page.
EU | Revised GVP Module III Strengthens PV Oversight Across NIS, While Imposed-PASS Registration Becomes Legally Binding
Please login to view this page.
BRAZIL | INAEP Clarifies Single Ethics Review and AI Use in Human Research — Practical Implications for Multi-Centre NIS
Please login to view this page.
USA | FDA Explores GenAI Medical Device Framework — RWD Could Shape Premarket and Postmarket Evidence
Please login to view this page.
GREECE | Legacy NIS Circulars Face 1 October Publication Test
Please login to view this page.
CANADA | CDA Sets Expectations for AI-Generated RWE — Human Oversight, Validation and Transparency Required
Please login to view this page.
USA | FDA Reissues Draft Guidance on Substantial Evidence of Effectiveness — Non-Interventional Studies Expressly Recognised Within the Adequate and Well-Controlled Investigation Framework GalleryUSA | FDA Reissues Draft Guidance on Substantial Evidence of Effectiveness — Non-Interventional Studies Expressly Recognised Within the Adequate and Well-Controlled Investigation Framework
USA | FDA Reissues Draft Guidance on Substantial Evidence of Effectiveness — Non-Interventional Studies Expressly Recognised Within the Adequate and Well-Controlled Investigation Framework
Please login to view this page.
UK | HRA Updates Timeline for New Plan and Manage Health and Care Research Service (IRAS Replacement)
Please login to view this page.









